Article
Treatment of a metabolic liver disease by in vivo prime editing in mice
medRxiv · 2021 · Boeck, D.; Rothgangl, T.; Villiger, L.; Schmidheini, L.; Mathis, N.; Ioannidi, E.; Kontarakis, Z.; Kreutzer, S.; Rimann, N.; Grisch-Chan, H. M.; Thoeny, B.; Schwank, G.
Key facts
| Title | Treatment of a metabolic liver disease by in vivo prime editing in mice |
|---|---|
| First author | Boeck, D.; Rothgangl, T.; Villiger, L.; Schmidheini, L.; Mathis, N.; Ioannidi, E.; Kontarakis, Z.; Kreutzer, S.; Rimann, N.; Grisch-Chan, H. M.; Thoeny, B.; Schwank, G. |
| Journal | medRxiv |
| Published | Aug 17, 2021 |
| DOI | 10.1101/2021.08.17.456632 |
| Devices mentioned | K001122, K010722, K022269, K032420, K051701, K132580, K133356, K163152, K172089, K180829, K181268, K181652 and 18 more |
| Product codes mentioned | CIT, DXZ, GAW, FTL, GAM, JJH, PFF, PFT, FTM, FZP, GAQ, GCJ and 2 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1